Colorectal liver metastases (CRLM), cancer that has spread from the colon or rectum to the liver, have a deadly reputation. Due to its pervasive spread, typical cancer treatments like chemotherapy and surgical resection often prove ineffective. For the few patients who benefit from treatment, 75% still experience recurrence within two years and have poor survival outcomes.
Continue Reading this article here
